Literature DB >> 11933032

Selection models and pattern-mixture models to analyse longitudinal quality of life data subject to drop-out.

Bart Michiels1, Geert Molenberghs, Luc Bijnens, Tony Vangeneugden, Herbert Thijs.   

Abstract

Longitudinally observed quality of life data with large amounts of drop-out are analysed. First we used the selection modelling framework, frequently used with incomplete studies. An alternative method consists of using pattern-mixture models. These are also straightforward to implement, but result in a different set of parameters for the measurement and drop-out mechanisms. Since selection models and pattern-mixture models are based upon different factorizations of the joint distribution of measurement and drop-out mechanisms, comparing both models concerning, for example, treatment effect, is a useful form of a sensitivity analysis. Copyright 2002 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  2002        PMID: 11933032     DOI: 10.1002/sim.1064

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  10 in total

Review 1.  Analytic Considerations for Repeated Measures of eGFR in Cohort Studies of CKD.

Authors:  Haochang Shou; Jesse Y Hsu; Dawei Xie; Wei Yang; Jason Roy; Amanda H Anderson; J Richard Landis; Harold I Feldman; Afshin Parsa; Christopher Jepson
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-27       Impact factor: 8.237

2.  Effect of Demographic Risk Factors on the Change in Cognitive Function in the Presence of Non-Participation and Truncation due to Death.

Authors:  Kumar B Rajan; Sue E Leurgans; Jennifer Weuve; Todd L Beck; Denis A Evans
Journal:  J Biom Biostat       Date:  2011-11-18

3.  A Bayesian shared parameter model for joint modeling of longitudinal continuous and binary outcomes.

Authors:  T Baghfalaki; M Ganjali; A Kabir; A Pazouki
Journal:  J Appl Stat       Date:  2020-09-18       Impact factor: 1.416

4.  Cervical spondylotic myelopathy surgical trial: randomized, controlled trial design and rationale.

Authors:  Zoher Ghogawala; Edward C Benzel; Robert F Heary; K Daniel Riew; Todd J Albert; William E Butler; Fred G Barker; John G Heller; Paul C McCormick; Robert G Whitmore; Karen M Freund; J Sanford Schwartz
Journal:  Neurosurgery       Date:  2014-10       Impact factor: 4.654

5.  Bayesian hierarchical models for network meta-analysis incorporating nonignorable missingness.

Authors:  Jing Zhang; Haitao Chu; Hwanhee Hong; Beth A Virnig; Bradley P Carlin
Journal:  Stat Methods Med Res       Date:  2015-07-28       Impact factor: 3.021

6.  The king's foot of patient-reported outcomes: current practices and new developments for the measurement of change.

Authors:  Richard J Swartz; Carolyn Schwartz; Ethan Basch; Li Cai; Diane L Fairclough; Lori McLeod; Tito R Mendoza; Bruce Rapkin
Journal:  Qual Life Res       Date:  2011-02-19       Impact factor: 4.147

7.  On the impact of nonresponse in logistic regression: application to the 45 and Up study.

Authors:  Joanna J J Wang; Mark Bartlett; Louise Ryan
Journal:  BMC Med Res Methodol       Date:  2017-05-08       Impact factor: 4.615

8.  Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17.

Authors:  B Cuer; C Mollevi; A Anota; E Charton; B Juzyna; T Conroy; C Touraine
Journal:  BMC Med Res Methodol       Date:  2020-09-03       Impact factor: 4.615

Review 9.  Regression methods for investigating risk factors of chronic kidney disease outcomes: the state of the art.

Authors:  Julie Boucquemont; Georg Heinze; Kitty J Jager; Rainer Oberbauer; Karen Leffondre
Journal:  BMC Nephrol       Date:  2014-03-14       Impact factor: 2.388

10.  A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis plan.

Authors:  Rebecca Walwyn; Laura Potts; Paul McCrone; Anthony L Johnson; Julia C DeCesare; Hannah Baber; Kimberley Goldsmith; Michael Sharpe; Trudie Chalder; Peter D White
Journal:  Trials       Date:  2013-11-13       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.